Profile for Cyprus Patent: 1123974
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Cyprus Patent: 1123974
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 7,838,564 | Mar 7, 2026 | Helsinn | VALCHLOR | mechlorethamine hydrochloride |
| 7,872,050 | Jul 8, 2029 | Helsinn | VALCHLOR | mechlorethamine hydrochloride |
| 8,450,375 | Mar 7, 2026 | Helsinn | VALCHLOR | mechlorethamine hydrochloride |
| 8,501,818 | Mar 7, 2026 | Helsinn | VALCHLOR | mechlorethamine hydrochloride |
| 8,501,819 | Mar 7, 2026 | Helsinn | VALCHLOR | mechlorethamine hydrochloride |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
